Artivion, Inc.
AORT
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. Itā¦ read more
Healthcare
Medical Devices
32 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$46.53
Price-0.64%
-$0.30
1Y
Price
Market Cap
$2.204b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+16.7%
EBITDA Margin+5.7%
Net Profit Margin+14.0%
Free Cash Flow MarginRevenue
$422.646m
+8.8%
1y CAGR+10.5%
3y CAGR+9.1%
5y CAGREarnings
-$9.141m
+31.6%
1y CAGR+9.4%
3y CAGR-0.3%
5y CAGREPS
-$0.24
+25.0%
1y CAGR+8.7%
3y CAGR-0.1%
5y CAGRBook Value
$438.694m
$857.662m
Assets$418.968m
Liabilities$261.989m
DebtDebt to Assets
30.6%
5.8x
Debt to EBITDAFree Cash Flow
$15.750m
+42.6%
1y CAGR+70.4%
3y CAGR+52.5%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company